Metabolic properties of vasodilating beta blockers: management considerations for hypertensive diabetic patients and patients with the metabolic syndrome.

Journal of clinical hypertension (Greenwich, Conn.)

Volumn 6, Issue 12, 2004, Pages 690-696

  Jacob, Stephan ^a   Henriksen, Erik J ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; INSULIN;

BLOOD; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; REVIEW; RISK FACTOR; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; METABOLIC SYNDROME X; RISK FACTORS; VASODILATION;

EID: 28744454527     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2004.03704.x     Document Type: Review

References (51)